APR 10, 2018 6:09 AM PDT

New Biomarker Improves Combination Cancer Therapy

WRITTEN BY: Kara Marker

Two anti-cancer drugs are better than one, and the discovery of a new biomarker will likely help researchers identify the appropriate timing for the administration of multiple treatments for cancer patients. From Osaka University and Elsevier, researchers show how a new biomarker helps scientists visualize blood vessel activity.

Cross section of a blood vessel. Source: Doc. RNDr. Josef Reischig, CSc

Drugs that inhibit angiogenesis, the formation of new blood vessels, are important in the fight against cancer because new blood vessels are required for cancer growth. “Adding an anti-angiogenic drug can boost an anticancer drug's effectiveness,” explained Nobuyuki Takakura, MD, PhD. “Basic research indicates that anti-angiogenic therapy allows the blood vessels to return to quiescence and "normalize" so that the anticancer drug can penetrate the tumor more effectively.”

Combination therapies such as the approach that Takakura describes could do wonders for the world of cancer treatment, if done right. Angiogenesis inhibitors, like vascular endothelial growth factor (VEGF) signaling can improve the effectiveness of anticancer drugs, like chemotherapy; most of the time, one drug can’t keep cancer in check all on its own. Researchers are hoping that by improving combination anti-cancer therapies, they can help cancer survivors live longer without relapse.

“However, it is unclear how we can recognize the 'window of opportunity' for the tumor vascular normalizing period for effective timing of anticancer drug treatment,” Takakura explained. “Therefore, biomarkers delineating this window are essential.”

Takakura’s research involves breaking down the difference between dormant and active proliferating vascular endothelial cells (ECs). The new biomarker, promoter activity of a particular DNA replication factor, was measured in ECs to do so. ECs form the lining of blood vessels and are important for supplying the tissues with blood.

Researchers saw no biomarker activity in normal adult skin vasculature, but ECs in and around tumor cells showed signs of activity, which was ultimately linked with tumor cell growth. Takakura said that this activity “may be utilized to visualize proliferating ECs.”

Non-proliferative ECs also express a cell surface protein called CD10, which Takakura also lists as a potential biomarker: "Since CD109 is highly expressed in dormant ECs, we suggest it can be used to detect normalized blood vessels, thus allowing identification of the 'window of opportunity' for optimal delivery of chemotherapeutics.”

The present study was published in the American Journal of Pathology.

Sources: Elsevier, Molecular Biology of the Cell, 4th Edition

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 27, 2021
Clinical & Molecular DX
Breakthrough Diagnostic Detects TB Infections in Infants Sooner
MAY 27, 2021
Breakthrough Diagnostic Detects TB Infections in Infants Sooner
There are nearly a million cases of tuberculosis (TB) every year, and over 80 percent of childhood deaths from TB occur ...
JUN 04, 2021
Cannabis Sciences
Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis
JUN 04, 2021
Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis
Researchers from contract research organization, KGK Science, working on behalf of neurotechnology firm Zentrela, have f ...
JUN 16, 2021
Clinical & Molecular DX
Rapid Screening Tool Provides Insights on Brain Health
JUN 16, 2021
Rapid Screening Tool Provides Insights on Brain Health
Scientists at King’s College London have identified a single biomarker that can be used to diagnose a range of neu ...
JUL 15, 2021
Clinical & Molecular DX
Childhood Lead Exposure Influences Personality in Adulthood
JUL 15, 2021
Childhood Lead Exposure Influences Personality in Adulthood
Exposure to toxic chemicals in childhood could have unlikely effects on personality, and behavioral traits in adulthood, ...
AUG 15, 2021
Microbiology
Lyme Disease Linked to Significantly Increased Suicide Risk
AUG 15, 2021
Lyme Disease Linked to Significantly Increased Suicide Risk
While about 30,000 cases of Lyme disease are reported to the CDC every year, the disease has been estimated to cause abu ...
AUG 19, 2021
Cancer
Vitamin D Reduces Risk of Early-Onset Colorectal Cancer
AUG 19, 2021
Vitamin D Reduces Risk of Early-Onset Colorectal Cancer
Colorectal cancer (CRC) is the third most diagnosed type of cancer in both men and women in the United States and CRC in ...
Loading Comments...